Compliance Rate

Compliance Rate 100.0%
Compliant submissions 1
Incompliant submissions 0
Total trials 1

My Organizations' Clinical Trials

Showing 1025 of 3173 entries
View as:

Ibrance Real World Insights

Phase: N/A Priority: Normal
NCT ID: NCT03159195 Org: User:
Start: 06/12/17 End: 06/24/21 Due: 06/24/22

Safety And Efficacy Of Rescriptor In Patients For Human Immunodeficiency Virus (HIV) Patients

Phase: N/A Priority: Normal
NCT ID: NCT00823966 Org: User:
Start: 12/31/03 End: 03/31/09 Due: 03/31/10

A Study to Investigate the Effects of Sisunatovir on QTc Interval in Healthy Adult Participants.

Phase: N/A Priority: Normal
NCT ID: NCT05878522 Org: User:
Start: 05/15/23 End: 10/30/23 Due: 10/30/24

POC Study in Partially Responsive Generalized Anxiety Disorder

Phase: N/A Priority: Normal
NCT ID: NCT02310568 Org: User:
Start: 11/30/14 End: 10/31/15 Due: 10/31/16

Relative Bioavailability Of Two Formulations Of Moroctocog Alfa (AF-CC)

Phase: N/A Priority: Normal
NCT ID: NCT01579903 Org: User:
Start: 08/31/12 End: 01/31/13 Due: 01/31/14

A STUDY TO EVALUATE THE EFFECT OF PF-06651600 ON PHARMACOKINETICS OF SINGLE DOSE SUMATRIPTAN IN HEALTHY PARTICIPANTS.

Phase: N/A Priority: Normal
NCT ID: NCT04355845 Org: User:
Start: 06/15/20 End: 08/10/20 Due: 08/10/21

A Study to Learn About The COVID-19 (Study) Vaccine (Called COMIRNATY) in People That Are Less Than 21 Years Old.

Phase: N/A Priority: Normal
NCT ID: NCT05295290 Org: User:
Start: 11/21/22 End: 11/21/30 Due: 11/21/31

A Study to Learn About Somatrogon in Patients With Pediatric Growth Hormone Deficiency (p GHD) in India.

Phase: N/A Priority: Normal
NCT ID: NCT06587035 Org: User:
Start: 01/30/25 End: 12/24/26 Due: 12/24/27

S.I.F.A. II: Prevention Of Thromboembolic Events In Patients With Nonrheumatic Atrial Fibrillation

Phase: N/A Priority: Normal
NCT ID: NCT00244426 Org: User:
Start: 12/31/00 End: 04/30/08 Due: 04/30/09

FSME IMMUN NEW Follow-up to Study 205 in Children Aged 6 to 16 Years

Phase: N/A Priority: Normal
NCT ID: NCT00161889 Org: User:
Start: 02/28/02 End: 08/31/02 Due: 08/31/03

A Study In Patients With Non-Small Cell Lung Cancer To Test If Erlotinib Plus SU011248 Is Better Than Erlotinib Alone

Phase: N/A Priority: Normal
NCT ID: NCT00457392 Org: User:
Start: 07/31/07 End: 12/31/12 Due: 12/31/13

Retrospective Observational Research Study to Describe the Real World Use of Bosutinib in a Single Centre in Scotland

Phase: N/A Priority: Normal
NCT ID: NCT05363488 Org: User:
Start: 10/08/21 End: 10/08/21 Due: 10/08/22

A Phase 1 Study To Evaluate The Safety And Tolerability Of PF-06252616 In Healthy Subjects

Phase: N/A Priority: Normal
NCT ID: NCT01616277 Org: User:
Start: 06/30/12 End: 08/31/14 Due: 08/31/15

Safety and Pharmacokinetic Study of PF-06700841 in Japanese Healthy Volunteers

Phase: N/A Priority: Normal
NCT ID: NCT03236493 Org: User:
Start: 08/16/17 End: 10/12/17 Due: 10/12/18

An Open-Label, Randomized, Multicenter Trial of Encorafenib + Binimetinib Evaluating a Standard-dose and a High-dose Regimen in Patients With BRAFV600-mutant Melanoma Brain Metastasis

Phase: N/A Priority: Normal
NCT ID: NCT03911869 Org: User:
Start: 04/30/19 End: 01/27/22 Due: 01/27/23

An Open Label, Randomized, Crossover Study To Estimate The Pharmacokinetics And Evaluate The Safety Following A Single Dose Of Azithromycin 2g Extended-Release Powder For Oral Suspension With A 3-Day Dosing Regimen Of Azithromycin 500mg Tablet In Chinese Healthy Male Subjects

Phase: N/A Priority: Normal
NCT ID: NCT00879983 Org: User:
Start: 05/31/09 End: 07/31/09 Due: 07/31/10

An Investigational Drug, Palbociclib (PD-0332991), Is Being Studied In Combination With Velcade And Dexamethasone In Patients With Multiple Myeloma. Patients Must Have Received Prior Treatment For Multiple Myeloma.

Phase: N/A Priority: Normal
NCT ID: NCT00555906 Org: User:
Start: 01/31/08 End: 03/31/13 Due: 03/31/14

Absorption and Systemic Study of AN2690 in Patients With Moderate to Severe Onychomycosis (ADME I)

Phase: N/A Priority: Normal
NCT ID: NCT00680160 Org: User:
Start: 04/30/06 End: 05/09/07 Due: 05/09/08

An Investigation of Effectiveness and Safety of Varenicline Tartrate in Helping People Quit Smoking

Phase: N/A Priority: Normal
NCT ID: NCT00371813 Org: User:
Start: 09/30/06 End: 06/30/07 Due: 06/30/08

Evaluation of Pharmacokinetics, Safety, and Tolerability of Ceftazidime-avibactam in Neonates and Infants.

Phase: N/A Priority: Normal
NCT ID: NCT04126031 Org: User:
Start: 01/14/20 End: 12/30/22 Due: 12/30/23

Hepatic Impairment Study For Crizotinib In Advanced Cancer Patients

Phase: N/A Priority: Normal
NCT ID: NCT01576406 Org: User:
Start: 07/31/12 End: 06/30/16 Due: 06/30/17

A Trial to Assess the Safety, Tolerability, and Immunogenicity of Bivalent rLP2086 Vaccine When Given to Healthy Young Adults Aged >=18 to <26 Years.

Phase: N/A Priority: Normal
NCT ID: NCT01352845 Org: User:
Start: 05/31/13 End: 02/28/15 Due: 02/28/16

CP-751871 In Treating Women With Early-Stage Breast Cancer That Can Be Removed By Surgery

Phase: N/A Priority: Normal
NCT ID: NCT00635245 Org: User:
Start: - End: - Due: -

Open Label Extension Study Evaluating Safety and Tolerability of AAB-003 (PF-05236812) in Subject With Mild to Moderate Alzheimer's Disease

Phase: N/A Priority: Normal
NCT ID: NCT01369225 Org: User:
Start: 07/31/11 End: 08/31/14 Due: 08/31/15

A Dose Finding Study To Evaluate Safety, Drug Interaction, Tumor Markers Of Axitinib In Combination With MK-3475 In Adult Patients With Previously Untreated Advanced Renal Cell Cancer

Phase: N/A Priority: Normal
NCT ID: NCT02133742 Org: User:
Start: 09/16/14 End: 07/03/19 Due: 07/03/20